The impact of the COVID-19 pandemic on patients with migraine.
SAGE Open Med
; 11: 20503121231170726, 2023.
Article
in English
| MEDLINE | ID: covidwho-2315438
ABSTRACT
Objectives:
The aim of our work was to assess the impact of the COVID-19 pandemic and quarantine measures on migraine patients in regards to the activity of the disease, the psycho-emotional background of the patients and their quality of life.Methods:
his study included 133 patients with established diagnosis of migraine. All study participants were divided into two clinical groups A-patients with chronic and episodic forms of migraine, who had a history of positive PCR test for COVID-19, and B-patients with chronic and episodic forms of migraine who did not have a history of coronavirus disease.Results:
We detected increase in the number of antimigraine medication (p = 0.04), frequency of headache attacks (p = 0.01), and the psycho-emotional state deterioration (increase in the Hamilton anxiety scale score) (p = 0.002) in patients after recovery from the coronavirus disease. There was no significant difference in the headache's intensity according to the VAS scale (p = 0.51) as well as in the dynamics of the Beck depression scale score (p = 0.09) before and after the COVID-19 infection.Conclusion:
Patients with a history of migraine who recovered from COVID-19 showed increased frequency of migraine headache attacks and anxiety.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
SAGE Open Med
Year:
2023
Document Type:
Article
Affiliation country:
20503121231170726
Similar
MEDLINE
...
LILACS
LIS